Investing

Acceleration of RAD204 Phase 1 dose escalation trial

May 12, 2025 Investing 1 Min Read

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name
Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Investing
Rare Earths Market Update: H1 2025 in Review
August 19, 2025

Investing
Danielle DiMartino Booth: Fed’s Next Move as Dissent Builds, Where to Focus Now
August 19, 2025

Investing
Graphite Resource Expansion Sets Project up as World-Class
August 19, 2025

Investing
Top 5 Canadian Cobalt Stocks of 2025
August 19, 2025
Categories
- Business (172)
- Investing (455)
- Politics (530)
- Stock (176)